drugset / Trial / NCT00398476

Fluticasone Nasal Spray Patient Preference Study

NCT00398476

Phase 3 Completed 127 enrolled GlaxoSmithKline
RandomizedCrossoverTreatment

Summary

The objectives of this study are to evaluate and compare patient preference for FF (Fluticasone Furoate) and FP (Fluticasone Propionate Aqueous)nasal sprays in the treatment of allergic rhinitis following single-dose administration.

Timeline

Start
2006-12-01
Primary completion
2006-12-04
Completion
2006-12-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Furoate Other / unclassified 110 ug Intranasal
Comparator Fluticasone propionate Other / unclassified 200 ug Intranasal